Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Non-Malignant Channel

Explore the latest updates and expert interviews

The Non-Malignant Channel on VJHemOnc is supported by BioMarin Pharmaceutical Inc and Agios Pharmaceuticals. This supporter has no influence over the production of the content.

Latest Videos Sessions Features Anemias Autoimmune Disorders Bleeding Disorders Podcasts Other Disorders Expert Editorial Board

Welcome to The Non-Malignant Channel.

Alongside a world-leading Editorial Board, explore the latest updates in non-malignant blood disorders. Speaking directly with the experts at international congresses, The Non-Malignant Channel brings you video interviews, podcasts, roundtable discussions and more.

Conferences

CAR-T Meeting 2024
ASH 2023
ASCAT 2023
ISTH 2023
EHA 2023
ASH 2022
1:54
CAR-Tregs hold potential for the treatment of autoimmune disease
Matteo Doglio • 16 Feb 2024
2:29
The importance of a multidisciplinary team when treating autoimmune disease with CAR T-cell therapy
Raffaella Greco • 2 Feb 2024
2:55
CAR-T in the field of autoimmune disease
Raffaella Greco • 2 Feb 2024
1:47
A session exploring CAR-T in autoimmune disease at the CAR-T Meeting 2024
Raffaella Greco • 2 Feb 2024
View All Videos
1:23
Developing a PRO collection tool for patients with SCD: key themes which are important to patients
Nirmish Shah • 8 Dec 2023
0:59
HdxSim: a clinical decision support tool for model-informed precision dosing of hydroxyurea in SCD
Alexandra Power-Hays • 11 Dec 2023
1:09
Emerging treatment options for refractory immune thrombocytopenia
Hanny Al-Samkari • 9 Dec 2023
1:25
Improving the sensitivity of platelet autoantibody testing for ITP diagnosis
Hanny Al-Samkari • 9 Dec 2023
View All Videos
4:33
The assessment and management of pain in patients with thalassemia
Perla Eleftheriou • 24 Oct 2023
1:10
Upcoming novel agents for the treatment of sickle cell disease
Perla Eleftheriou • 24 Oct 2023
4:10
GBT_HOPE trial: patient experiences of voxelotor as a treatment for SCD
Perla Eleftheriou • 24 Oct 2023
2:57
Global initiatives in SCD and the role of the Lancet Commission
Subarna Chakravorty • 26 Oct 2023
View All Videos
2:15
Emicizumab prophylaxis instead of immunosuppressive therapy in patients with acquired hemophilia A
Andreas Tiede • 25 Jun 2023
2:33
Unmet needs and emerging treatments in von Willebrand disease
Caterina Casari • 26 Jun 2023
2:06
Current unmet needs in ITP: impaired quality of life & chronic disorders
Paolo Gresele • 27 Jun 2023
0:52
Unmet needs and emerging approaches in the treatment of von Willebrand disease
Melanie Daniel • 25 Jun 2023
View All Videos
0:55
The importance of thrombosis and hemostasis in hematology & hot topics in hemophilia research
Riitta Lassila • 10 Jun 2023
1:17
Emerging strategies to support patients with hemophilia A
Riitta Lassila • 10 Jun 2023
1:43
Quality of life in patients with hemophilia: the impact of bleeds & the benefits of gene therapy
Riitta Lassila • 10 Jun 2023
1:06
Overview of the diagnostic work-up for hemophilia
Riitta Lassila • 10 Jun 2023
View All Videos
1:53
Synergistic combination of RAP-GRL & TMPRSS6-ASO in β-thalassemia
Stefano Rivella • 11 Dec 2022
8:50
Updates from the HOPE-B trial: etranacogene dezaparvovec in adults with hemophilia B
Steven Pipe • 12 Dec 2022
6:11
HAVEN 7: emicizumab prophylaxis for the treatment of infants with severe hemophilia A
Steven Pipe • 12 Dec 2022
1:11
Novel mouse model to investigate the pathophysiology of alpha-thalassemia
Stefano Rivella • 11 Dec 2022
View All Videos
The Non-Malignant Channel on VJHemOnc is supported by BioMarin Pharmaceutical Inc and Agios Pharmaceuticals. This supporter has no influence over the production of the content.
If you are interested in becoming a supporter of The Non-Malignant Channel, please contact us

The content of VJHemOnc is intended for healthcare professionals